TrialJournal of neuro-oncology2020
Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
Chae-Yong Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it